1. P916: COEXISTENCE OF ≥2 HIGH-RISK MOLECULAR ABNORMALITIES SUPERVENES THE PROGNOSTIC VALUE OF THE REVISED INTERNATIONAL STAGING SYSTEM FOR MYELOMA: REAL-WORLD DATA ANALYSIS FROM THE GREEK MYELOMA STUDY GROUP. (23rd June 2022) Authors: Katodritou, E.; Dalampira, D.; Triantafyllou, T.; Gavriatopoulou, M.; Delimpasi, S.; Pouli, A.; Papadopoulou, T.; Verrou, E.; Sevastoudi, A.; Tsirou, K.; Katsika, L.; Douganiotis, G.; Karampatzakis, N.; Metallinou, T.-E.; Palaska, V.; Kotsopoulou, M.; Lalayianni, C.; Kyrtsonis, M.-C.; Spanoudakis... Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 806 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. PB1957: CIRCULATING MIRNA-16 AND MIRNA -21 EXPRESSION LEVELS IN MYELOMA; PRELIMINARY RESULTS. (23rd June 2022) Authors: Gkioka, A.-I.; Tsota, M.; Papadatou, M.; Gkiokas, A.; Alexandropoulos, A.; Bartzi, V.; Dedousis, G. V.; Kyrtsonis, M.-C. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1830 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Topic: AS06-Prognosis/AS06b-Predictive factors of response to treatment: NOVEL PREDICTIVE INDICATORS IN PATIENTS WITH HIGHER-RISK MYELODYSPLASTIC NEOPLASMS (HR-MDS) TREATED WITH 5-AZACYTIDINE: CUMULATIVE DATA FROM THE HELLENIC MDS STUDY GROUP. (May 2023) Authors: Kotsianidis, I.; Hatzimichael, E.; Pappa, V.; Galanopoulos, A.; Kourakli, A.; Diamantopoulos, P.; Papageorgiou, S.; Liapis, K.; Papadopoulos, V.; Papoutselis, M.; Bouchla, A.; Georgoulis, V.; Vassilakopoulos, T.; Solomou, E.; Dimou, M.; Vassilopoulos, G.; Vardi, A.; Papaioannou, M.; Pontikoglou, ... Journal: Leukemia research Issue: Volume 128(2023)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗